FREE Case Review (866) 588-0600

Advair Inhaler Lawsuit


The U.S. Food & Drug Administration (FDA) recently required GlaxoSmithKline, the maker of the popular asthma inhaler Advair (fluticasone and salmeterol) to add new warnings on the product labeling warning of an increased risk of hospitalization and death.

The Problem With LABAs

Advair belongs to a class of inhalers called Long-Acting Beta-Agonists (LABAs).

Advair inhalers relax the muscles in bronchial passages, allowing more air to flow. The medication generally provides immediate relief to asthma sufferers but unfortunately, does not treat the underlying inflammation. This creates the risk of a life-threatening condition.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition